Clinical Trial Update: Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of modified citrus pectin on PSA kinetics in biochemically recurrent prostate cancer after PSA increases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostatic Neoplasms

Drugs mentioned

• Modified Citrus Pectin

Snippet

Sponsor: EcoNugenics | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED